NCT06634628View on ClinicalTrials.gov

iMagemHTT- 009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

September 30, 2026

Conditions
Huntington DiseaseHDPET TracerPositron Emission TomographyRadioligandImagingmHTTHuntington'sHuntington's Disease
Interventions
RADIATION

Radioligand [11C]CHDI-00491009

Intravenous injection of radioligand in the arm with PET imaging of the brain.

Trial Locations (1)

3000

Universitaire Ziekenhuizen Leuven/ UZ Leuven/ UZL, Leuven

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

lead

CHDI Foundation, Inc.

OTHER